Hamamatsu Pharma Research (HPR) is a leading preclinical research company based in San Diego, CA, specializing in translational research innovations for novel therapeutics. With a focus on high-quality drug efficacy testing, HPR offers a range of services in disease models, in vivo imaging, and pain evaluation, catering to various medical needs in central nervous system, ophthalmology, and gastroenterology.
With a unique approach to preclinical research, HPR utilizes cynomolgus macaque-based models, known for their genetic closeness to humans, to provide valuable insights and enhance the significance of preclinical findings. Additionally, HPR employs clinical-grade noninvasive neuroimaging techniques to measure stimulus-evoked brain activation, offering a quantifiable outcome measure for pain evaluation. Committed to advancing research, HPR's expertise and services aim to elevate scientific investigations to the next level.
Generated from the website